Arlington Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.36M | Buy |
10,763
+2,744
| +34% | +$1.11M | 1.61% | 39 |
|
|
2025
Q1 | $3.99M | Buy |
8,019
+1,061
| +15% | +$528K | 1.57% | 36 |
|
|
2024
Q4 | $3.62M | Buy |
6,958
+307
| +5% | +$160K | 1.41% | 44 |
|
|
2024
Q3 | $4.11M | Buy |
6,651
+1,053
| +19% | +$651K | 1.61% | 39 |
|
|
2024
Q2 | $3.1M | Buy |
5,598
+111
| +2% | +$61.4K | 1.54% | 49 |
|
|
2024
Q1 | $3.19M | Sell |
5,487
-159
| -3% | -$92.4K | 1.62% | 29 |
|
|
2023
Q4 | $3M | Buy |
5,646
+62
| +1% | +$32.9K | 0.86% | 40 |
|
|
2023
Q3 | $2.83M | Buy |
5,584
+5,374
| +2,559% | +$2.72M | 1.16% | 28 |
|
|
2023
Q2 | $110K | Sell |
210
-25
| -11% | -$13K | 0.02% | 231 |
|
|
2023
Q1 | $135K | Buy |
235
+64
| +37% | +$36.9K | 0.02% | 164 |
|
|
2022
Q4 | $94.2K | Hold |
171
| – | – | 0.01% | 157 |
|
|
2022
Q3 | $87K | Hold |
171
| – | – | 0.03% | 149 |
|
|
2022
Q2 | $93K | Hold |
171
| – | – | 0.03% | 170 |
|
|
2022
Q1 | $101K | Hold |
171
| – | – | 0.03% | 178 |
|
|
2021
Q4 | $114K | Buy |
171
+125
| +272% | +$83.3K | 0.03% | 185 |
|
|
2021
Q3 | $26K | Hold |
46
| – | – | 0.01% | 320 |
|
|
2021
Q2 | $23K | Hold |
46
| – | – | 0.01% | 242 |
|
|
2021
Q1 | $21K | Hold |
46
| – | – | 0.01% | 301 |
|
|
2020
Q4 | $21K | Buy |
+46
| New | +$21K | 0.01% | 147 |
|